About News CareersSales TrainingInternational Center for BiotechnologyContact

 CRI Corporate News

View By Month:
January, 2018
December, 2017
November, 2017
October, 2017
September, 2017
August, 2017
Visit News Archive
Visit Publication Archive

GENEX Debuts Eight New Jersey Sires,
New Genetic Index for Commercial Jerseys

SHAWANO, Wisconsin — GENEX released eight new Jersey sires with the December sire summary, including 1JE01057 CESPEDES {3} – a bull that’s elite across indexes! At the same time, GENEX released the Ideal Commercial Cow (ICC$) index for Jerseys, a sire ranking tool that addresses the needs of commercial Jersey cattle producers.

CESPEDES {3} debuted second in the lineup for the new ICC$ index, behind producer favorite 1JE00892 VANDRELL {2}. CESPEDES {3} also ranks exceptionally well for Sustainability (SUST$), one of three ICC$ sub-indexes. SUST$ encompasses Productive Life, Livability, Somatic Cell Score, Mastitis Resistance, functional udder traits and the new GENEX proprietary trait, Calf Survivability. Furthermore, the Marlo son leads the industry with his outstanding +233 JPI™ and +839 Cheese Merit (CM$). Count on him for exceptional yield at +138 Combined Fat & Protein (CFP), daughter fertility (+1.4 Daughter Pregnancy Rate) and improved udders (+22.6 JUI™). CESPEDES {3} is available in GenChoice™ sexed semen only.

Another new graduate to the lineup is 1JE01056 COUSINS {3}, an Avon son at +856 ICC$, +689 CM$ and +199 JPI™. Rely on COUSINS {3} for his exceptional +19.4 JUI™. He’s a great choice for improving fertility in the next generation as well; he is +128 for the Fertility (FERT$) sub-index of ICC$, which includes Daughter Pregnancy Rate, Cow Conception Rate, Heifer Conception Rate, the fertility haplotypes and a new GENEX proprietary trait, Age at First Calving. Look for COUSINS {3} to be available in GenChoice™ semen.

1JE00994 ASTRIX {3} debuts at +816 ICC$, +662 CM$ and +189 JPI™. This Avon out of a Magnum meets the needs of producers looking to improve daughter fertility too; he stands at +3.2 DPR and +92 FERT$. ASTRIX {3} will improve udders (+18.3 JUI™) and is available in GenChoice™ semen.

1JE00991 GRIEZMANN {4} is an early Leonel son at +680 ICC$. His +136 CFP makes him a yield specialist and earns him a +599 for the Cheese Maximizer (ChMAX$) sub-index of ICC$. GRIEZMANN {4} is +180 JPI™ and +630 CM$ while maintaining a +18.7 JUI™.

A trio of VANDRELL {2} sons joined the lineup with impressive ICC$ index values. These sires include 1JE00992 CONTENDER {3} at +770 ICC$, 1JE00986 TAX {3} at +763 ICC$ and 1JE00998 FEARLESS {3} at +743 ICC$. Look to these sires for component production power as each is over +430 ChMAX$. CONTENDER {3} is available in GenChoice™ sexed semen.

1JE00999 CARPDIEM {3}, the final new graduate, is an Avon out of a Soprano that adds pedigree diversity. He is +722 ICC$, +599 CM$ and +177 JPI™. CARPDIEM {3} is +0.7 DPR and an udder specialist at +24.8 JUI™.

Other Highlights
VANDRELL {2} and 1JE00889 PROP JOE {3}, two bulls from the same maternal line, remain in the JPI™ top 10 for daughter-proven sires. Along with his +710 CM$ and +215 JPI™, VANDRELL {2} tops the GENEX ICC$ listing at +992 and is the FERT$ sub-index all-star at +182.

Adding more daughters to his proof, PROP JOE is now +775 ICC$, +693 CM$ and +191 JPI™. He offers an elite combination of udders (+22.0 JUI™), daughter fertility (+0.2 DPR) and exceptional PregCheck™ and PregCheck+™ sire fertility rankings.

1JE00966 FUTURE {3} at +895 ICC$, 1JE00984 USAIN BOLT {3} at +874 ICC$, 1JE00962 DEGROM {3} at +873 ICC$ and 1JE00971 CURRY {3} at +865 ICC$ all moved up in rank with the December proofs now standing at or above +200 JPI™.

To view the full GENEX lineup, click here.        

GENEX is the trusted provider of world-class animal genetics, progressive reproductive solutions, value-added products and innovative services. As a cooperative business, GENEX serves members and customers - dairy and beef cattle producers - across the United States. GENEX is part of Cooperative Resources International. For more information, please visit http://genex.crinet.com.